High postoperative serum levels of surfactant type B as novel prognostic markers for congenital heart surgery

Objective: Congenital heart diseases are observed in 5 to 8 of every 1000 live births. The presence of a valuable biomarker during the surgical periods may aid the clinician in a more accurate prognosis during treatment. Methods: For this reason, surfactant protein B plasma levels may help to evaluate patients with cardiac problems diminishing the alveolocapillary membrane stability. In this study, plasma levels of this biomarker were measured in the preoperative and postoperative periods. This study was conducted to detect the differences between pulmonary hypertensive and normotensive patients. The differences before and after cardiopulmonary bypass were examined. Results: The differences in cardiopulmonary bypass time, cross-clamp time , inotropic support dose, and duration of intensive care of patients with and without pulmonary hypertensive were found to be statistically significant (P<0.05). The results revealed that this pathophysiological state was related to other variables that were studied. We believe that the differences in preoperative and postoperative SPB levels could be attributed to alveolocapillary membrane damage and alveolar surfactant dysfunction. We found that this pathophysiological condition was significantly associated with postoperative parameters. Conclusion: The findings of the current study showed that surfactant protein B was present in the blood of patients with a congenital heart disease during the preoperative period. Long by-pass times may exert damage to the alveolocapillary membrane in patients with pulmonary hypertension and preoperative heart failure, and it is recommended to keep the option of surfactant therapy in mind during the postoperative course at the intensive care unit before preparing the patients for extubation.

Saved in:
Bibliographic Details
Main Authors: Is?k,Onur, Disli,Olcay Murat, Bas,Tolga, Ayd?n,Hakan, Koç,Murat, Kutsal,Ali
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Cirurgia Cardiovascular 2014
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000200186
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0102-76382014000200186
record_format ojs
spelling oai:scielo:S0102-763820140002001862014-08-28High postoperative serum levels of surfactant type B as novel prognostic markers for congenital heart surgeryIs?k,OnurDisli,Olcay MuratBas,TolgaAyd?n,HakanKoç,MuratKutsal,Ali Heart Surgery Biological Markers Pulmonary Surfactant-Associated Protein B Heart Defects Congenital Objective: Congenital heart diseases are observed in 5 to 8 of every 1000 live births. The presence of a valuable biomarker during the surgical periods may aid the clinician in a more accurate prognosis during treatment. Methods: For this reason, surfactant protein B plasma levels may help to evaluate patients with cardiac problems diminishing the alveolocapillary membrane stability. In this study, plasma levels of this biomarker were measured in the preoperative and postoperative periods. This study was conducted to detect the differences between pulmonary hypertensive and normotensive patients. The differences before and after cardiopulmonary bypass were examined. Results: The differences in cardiopulmonary bypass time, cross-clamp time , inotropic support dose, and duration of intensive care of patients with and without pulmonary hypertensive were found to be statistically significant (P<0.05). The results revealed that this pathophysiological state was related to other variables that were studied. We believe that the differences in preoperative and postoperative SPB levels could be attributed to alveolocapillary membrane damage and alveolar surfactant dysfunction. We found that this pathophysiological condition was significantly associated with postoperative parameters. Conclusion: The findings of the current study showed that surfactant protein B was present in the blood of patients with a congenital heart disease during the preoperative period. Long by-pass times may exert damage to the alveolocapillary membrane in patients with pulmonary hypertension and preoperative heart failure, and it is recommended to keep the option of surfactant therapy in mind during the postoperative course at the intensive care unit before preparing the patients for extubation. info:eu-repo/semantics/openAccessSociedade Brasileira de Cirurgia CardiovascularBrazilian Journal of Cardiovascular Surgery v.29 n.2 20142014-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000200186en10.5935/1678-9741.20140039
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Is?k,Onur
Disli,Olcay Murat
Bas,Tolga
Ayd?n,Hakan
Koç,Murat
Kutsal,Ali
spellingShingle Is?k,Onur
Disli,Olcay Murat
Bas,Tolga
Ayd?n,Hakan
Koç,Murat
Kutsal,Ali
High postoperative serum levels of surfactant type B as novel prognostic markers for congenital heart surgery
author_facet Is?k,Onur
Disli,Olcay Murat
Bas,Tolga
Ayd?n,Hakan
Koç,Murat
Kutsal,Ali
author_sort Is?k,Onur
title High postoperative serum levels of surfactant type B as novel prognostic markers for congenital heart surgery
title_short High postoperative serum levels of surfactant type B as novel prognostic markers for congenital heart surgery
title_full High postoperative serum levels of surfactant type B as novel prognostic markers for congenital heart surgery
title_fullStr High postoperative serum levels of surfactant type B as novel prognostic markers for congenital heart surgery
title_full_unstemmed High postoperative serum levels of surfactant type B as novel prognostic markers for congenital heart surgery
title_sort high postoperative serum levels of surfactant type b as novel prognostic markers for congenital heart surgery
description Objective: Congenital heart diseases are observed in 5 to 8 of every 1000 live births. The presence of a valuable biomarker during the surgical periods may aid the clinician in a more accurate prognosis during treatment. Methods: For this reason, surfactant protein B plasma levels may help to evaluate patients with cardiac problems diminishing the alveolocapillary membrane stability. In this study, plasma levels of this biomarker were measured in the preoperative and postoperative periods. This study was conducted to detect the differences between pulmonary hypertensive and normotensive patients. The differences before and after cardiopulmonary bypass were examined. Results: The differences in cardiopulmonary bypass time, cross-clamp time , inotropic support dose, and duration of intensive care of patients with and without pulmonary hypertensive were found to be statistically significant (P<0.05). The results revealed that this pathophysiological state was related to other variables that were studied. We believe that the differences in preoperative and postoperative SPB levels could be attributed to alveolocapillary membrane damage and alveolar surfactant dysfunction. We found that this pathophysiological condition was significantly associated with postoperative parameters. Conclusion: The findings of the current study showed that surfactant protein B was present in the blood of patients with a congenital heart disease during the preoperative period. Long by-pass times may exert damage to the alveolocapillary membrane in patients with pulmonary hypertension and preoperative heart failure, and it is recommended to keep the option of surfactant therapy in mind during the postoperative course at the intensive care unit before preparing the patients for extubation.
publisher Sociedade Brasileira de Cirurgia Cardiovascular
publishDate 2014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000200186
work_keys_str_mv AT iskonur highpostoperativeserumlevelsofsurfactanttypebasnovelprognosticmarkersforcongenitalheartsurgery
AT disliolcaymurat highpostoperativeserumlevelsofsurfactanttypebasnovelprognosticmarkersforcongenitalheartsurgery
AT bastolga highpostoperativeserumlevelsofsurfactanttypebasnovelprognosticmarkersforcongenitalheartsurgery
AT aydnhakan highpostoperativeserumlevelsofsurfactanttypebasnovelprognosticmarkersforcongenitalheartsurgery
AT kocmurat highpostoperativeserumlevelsofsurfactanttypebasnovelprognosticmarkersforcongenitalheartsurgery
AT kutsalali highpostoperativeserumlevelsofsurfactanttypebasnovelprognosticmarkersforcongenitalheartsurgery
_version_ 1756429495578918912